ENO1 and pancreatic neoplasm: Multiple lines of evidence reveal that ENO1 is also present on the plasma membrane of cancer cells in non-small cell lung, breast, and pancreatic cancers (35–37), where it activates the plasminogen activator receptor (uPAR)/plasminogen/MMP axis, resulting in collagen degradation and cell invasion (38).